New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 8, 2014
07:20 EDTQCOR, MNKMallinckrodt shares pressured on lingering Acthar concerns, says Jefferies
Jefferies says shares of Mallinckrodt (MNK) sold off yesterday despite "significant accretion potential" from the Questcor (QCOR) acquisition due to lingering Acthar concerns relating to generic competition and the ongoing U.S. Attorney's investigation. The firm says its accretion math suggests $3 in earnings per share by FY15, which it feels justifies a $75-$85 share range for Mallinckrodt. It keeps a Buy rating on the stock with a $77 price target.
News For MNK;QCOR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 9, 2014
14:22 EDTMNKAetna updates clinical policy for H.P. Acthar Gel
Subscribe for More Information
December 4, 2014
12:33 EDTMNKMallinckrodt management to meet with Piper Jaffray
Meetings to be held in Baltimore on December 8 and in Atlanta on December 9 hosted by Piper Jaffray.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use